首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   83253篇
  免费   9998篇
  国内免费   3529篇
耳鼻咽喉   794篇
儿科学   655篇
妇产科学   595篇
基础医学   3555篇
口腔科学   1515篇
临床医学   8234篇
内科学   4696篇
皮肤病学   1164篇
神经病学   2017篇
特种医学   1630篇
外国民族医学   7篇
外科学   4466篇
综合类   20744篇
现状与发展   13篇
一般理论   23篇
预防医学   5664篇
眼科学   571篇
药学   9006篇
  256篇
中国医学   29437篇
肿瘤学   1738篇
  2024年   270篇
  2023年   1856篇
  2022年   2796篇
  2021年   4089篇
  2020年   4436篇
  2019年   3000篇
  2018年   2640篇
  2017年   3569篇
  2016年   3637篇
  2015年   3427篇
  2014年   7833篇
  2013年   6600篇
  2012年   7120篇
  2011年   7279篇
  2010年   5987篇
  2009年   4673篇
  2008年   3886篇
  2007年   4203篇
  2006年   3398篇
  2005年   2773篇
  2004年   2239篇
  2003年   1908篇
  2002年   1550篇
  2001年   1376篇
  2000年   1139篇
  1999年   863篇
  1998年   619篇
  1997年   567篇
  1996年   469篇
  1995年   419篇
  1994年   377篇
  1993年   252篇
  1992年   258篇
  1991年   225篇
  1990年   169篇
  1989年   132篇
  1988年   111篇
  1987年   98篇
  1986年   81篇
  1985年   96篇
  1984年   82篇
  1983年   50篇
  1982年   48篇
  1981年   42篇
  1980年   43篇
  1979年   24篇
  1978年   11篇
  1977年   16篇
  1976年   12篇
  1975年   7篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
肠易激综合征是临床常见的功能性胃肠病之一。由于多数患者的症状经过一线药物治疗后仍不能得到较好改善,许多患者为获得更好的治疗效果,转向选择补充与替代疗法进行治疗。然而,由于研究质量和数量的限制,大部分治疗肠易激综合征的补充与替代疗法并未被相关共识和指南所推荐。本文从补充与替代疗法的分类入手,从天然产品、身心治疗、传统医药3个方面就目前国内外常用的补充与替代疗法治疗肠易激综合征的研究进行概述,以期为临床工作者和患者更好地了解和应用提供帮助。  相似文献   
53.
目的:研究痛经的中医药辨治规律。方法:检索国家知识基础设施数据库(CNKI)1988—2019年应用中药治疗痛经的相关文献,采用Medcase Ver38诊籍中医师工作室-名老中医经验传承辅助平台,运用文本解析对临床医案进行研究。结果:研究文献131篇,医案104则,涉及病例128次,332诊次,涉及症状92条,病机33条,舌象27条,脉象17条,药物249种。结论:中医药治疗痛经的特异症状为“经行腹痛”,可见症为“夹血块、月经色暗、手足冰冷、经期腰酸”,相关舌脉为“舌质暗红,苔薄白”“脉沉细弦”,核心病机为“瘀血阻滞”,常用治法为“行气化瘀,活血止痛”,常用药物为“当归、白芍、甘草、延胡索、川芎”。  相似文献   
54.
《Genetics in medicine》2022,24(9):1814-1820
Although still in the early stages of development, the advent of fast, high-output, and cost-effective next-generation DNA sequencing technology is moving precision medicine into public health. Before this shift toward next-generation sequencing in public health settings, individual patients met geneticists after showing symptoms and through limited family screening. In the new era of precision public health, everyone is a possible participant in genetic sequencing, simply by being born (newborn screening), by donating blood (biobanking), or through population screening. These initiatives are increasingly offered to individuals throughout their life and more individuals are encountering opportunities to use DNA sequencing. This article raises awareness of these growing areas and calls for different models of public engagement and communication about genomics, including screening asymptomatic populations, obtaining consent for unspecified and unforeseen future uses of genomic data, and managing variants of uncertain significance. Given that such communication challenges loom large, established norms of practice in genomic medicine and research should be reconsidered.  相似文献   
55.
Network meta-analyses (NMAs) simultaneously estimate the effects of multiple possible treatment options for a given clinical presentation. For allergists to benefit optimally from NMAs, they must understand the process and be able to interpret the results. Through a worked example published in Pediatric Allergy and Immunology, we summarize how to identify credible NMAs and interpret them with a focus on recent innovations in the GRADE approach (Grading of Recommendations Assessment, Development, and Evaluation). NMAs build on traditional systematic reviews and meta-analyses that consider only direct paired comparisons by including indirect evidence, thus allowing the simultaneous assessment of the relative effect of all pairs of competing alternatives. Our framework informs clinicians of how to identify credible NMAs and address the certainty of the evidence. Trustworthy NMAs fill a critical gap in providing key inferences using direct and indirect evidence to inform clinical decision making when faced with more than two competing courses of treatment options. This document will help allergists to identify trustworthy NMAs to enhance patient care.  相似文献   
56.
57.
BackgroundBloating is a common gastrointestinal complaint which is difficult to treat.ObjectiveThis study investigated the efficacy and compliance of a formulation called KAASER comprised of Trachyspermum ammi (L.) Sprague seed, Zingiber officinale Roscoe. rhizome and Piper nigrum L. berry in the treatment of functional bloating.Design, setting, participants and interventionA total of 106 patients with functional bloating, between 20 and 50 years of age, participated in this double-blind randomized controlled trial. Patients were divided into 3 parallel groups that received 500 mg of placebo, dimethicone or KAASER, three times a day for 2 weeks.Main outcome measuresThe frequency and severity of bloating were primary outcomes, while the frequencies of eructation, defecation, borborygmus and early satiation were secondary outcomes. All parameters were evaluated at the beginning (week 0), and also weeks 2, 4 and 10 of the study, through self-report checklists with a scoring system.ResultsAmong the 84 patients who completed the study, the frequency and severity of bloating (P < 0.001), the frequencies of eructation, defecation and borborygmus (P = 0.03) were significantly improved in the group receiving KAASER (36 patients) compared with the dimethicone (35 patients) and placebo (35 patients) groups, during the 3 phases of follow-up. These significant differences persisted through the 2 and 8 weeks of follow-ups after cessation of medication (week 4 and 10). In early satiation, no significant differences were observed among the 3 groups.ConclusionThe results showed that KAASER can be effectively used to treat patients suffering from bloating. Bloating, eructation, defecation and borborygmus in the KAASER group remained significantly improved after 2 and 8 weeks of cessation of medication, making this mechanism an interesting area for further investigation.Trial registrationRegistration trial IRCT2015100324327N on Iranian Registry of Clinical Trials.  相似文献   
58.
卵巢癌属于妇科恶性肿瘤之一,其发病率逐年上升趋势,属中医的"癥瘕"范畴。秉承《素问》"阳化气,阴成形"之旨来探讨卵巢癌的病机及治疗,认为"阳化气"不足,"阴成形"太过为卵巢癌发病的一个重要原因,并由此提出温补阳气的卵巢癌治疗原则,指出该原则应贯穿整个卵巢癌治疗的始终。  相似文献   
59.
糖尿病渐以年轻化的趋势呈现,糖尿病周围神经病变(DPN)是糖尿病最常见的慢性并发症之一,因其高致残率严重影响病患的生活品质。本文简单阐述糖尿病周围神经病变的病因,并就中医药的角度对该病的治疗概况进行综述,以期为临床诊治提供新见解和新研究策略。  相似文献   
60.
彭成 《世界中医药》2020,15(9):1233-1236
系统中药学是基于现代中药学学科的开创者凌一揆教授"大中药"的思想,是研究中药复杂系统品种、品质、制药、药性、功效、应用等关键要素发生、发展、变化的科学。本文论述了系统中药学的科学内涵,报告了在系统中药学指导下益母草"品质制性效应"的研究实践。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号